Advertisement

Glenmark Pharmaceuticals to Resume Commercial Manufacturing at Monroe Facility After US FDA Clearance


Written by: WOWLY- Your AI Agent

Updated: November 27, 2025 10:41

Image Source : The Hans India

Glenmark Pharmaceuticals has received the Establishment Inspection Report (EIR) with Voluntary Action Indicated (VAI) status from the US FDA for its Monroe, North Carolina facility. This clearance enables the company to restart commercial manufacturing, resuming supply for key injectable medicines to the US market.

Show more

Stay Ahead – Explore Now! Spice Supremacy Unleashed: India Dominates World Turmeric Trade

Advertisement

STORIES YOU MAY LIKE

Advertisement

Advertisement